Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 7/24/23 → 7/24/25 |
Funding
- Ono Pharmaceutical: $87,979.00
23-NHL-30-OP (ONO-4059-09): An Open-label Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL)
- Munker, Reinhold (PI)